JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 2 167-175
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abi-Dargham, A.
Right arrow Articles by Innis, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abi-Dargham, A.
Right arrow Articles by Innis, R. B.

Reproducibility of SPECT Measurement of Benzodiazepine Receptors in Human Brain with Iodine-123-Iomazenil

Anissa Abi-Dargham, Mitchell Gandelman, Sami S. Zoghbi, Marc Laruelle, Ronald M. Baldwin, Penny Randall, Yolanda Zea-Ponce, Dennis S. Charney, Paul B. Hoffer and Robert B. Innis

Departments of Psychiatry and Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut and West Haven VA Medical Center, West Haven, Connecticut

Correspondence: For correspondence and reprints contact: Anissa Abi-Dargham, MD, Department of Psychiatry, Yale University and West Haven VA Medical Center/116A2, 950 Campbell Avenue, West Haven, CT 06516.

ABSTRACT

Iodine-123-iomazenil is a SPECT radiotracer used to image and quantify benzodiazepine receptors. The reproducibility of the measurement of benzodiazepine receptors in human brain with [123I]iomazenil and SPECT was investigated with a test/retest paradigm. Methods: Six subjects underwent two experiments during a 1-wk interval, Iodine-123-iomazenil was injected as a single bolus (12 mCi). The time-activity curves of the tracer in the arterial plasma were measured and corrected for metabolites. Regional time-activity curves of five brain regions were measured with the CERASPECT camera for 145 min postinjection with serial 2-min acquisitions. Data were analyzed using three kinetic models that included a two-compartment model, an unconstrained three-compartment model and a three-compartment model with a constraint on the nondisplaceable compartment. Results: The results from the various analyses and fitting strategies were compared. The variability (average absolute difference between test and retest, expressed as a percentage of the mean of both measurements) was 10% to 17%, depending on the outcome measure and the fitting procedure. The most reproducible outcome measure was the regional tracer distribution volume relative to the total arterial concentration (VT'). VT' showed an average regional variability of 10% ± 2%, with an intraclass correlation coefficient of 0.81. Conclusion: SPECT measurement of regional [123I]iomazenil VT' is reproducible and reliable. The use of regional ratios results in a significant loss of information.

Key Words: SPECT • iodine-123-iomazenil • reproducibility • benzodiazepine receptor




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
J. H. Krystal, J. Staley, G. Mason, I. L. Petrakis, J. Kaufman, R. A. Harris, J. Gelernter, and J. Lappalainen
{gamma}-Aminobutyric Acid Type A Receptors and Alcoholism: Intoxication, Dependence, Vulnerability, and Treatment.
Arch Gen Psychiatry, September 1, 2006; 63(9): 957 - 968.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. Millet, C. Graf, M. Moulin, and V. Ibanez
SPECT Quantification of Benzodiazepine Receptor Concentration Using a Dual-Ligand Approach
J. Nucl. Med., May 1, 2006; 47(5): 783 - 792.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. K. Staley, C. H. van Dyck, D. Weinzimmer, E. Brenner, R. M. Baldwin, G. D. Tamagnan, P. Riccardi, E. Mitsis, and J. P. Seibyl
123I-5-IA-85380 SPECT Measurement of Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility
J. Nucl. Med., September 1, 2005; 46(9): 1466 - 1472.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. M. Catafau, V. Perez, M. M. Penengo, S. Bullich, M. Danus, D. Puigdemont, J. C. Pascual, I. Corripio, J. Llop, J. Perich, et al.
SPECT of Serotonin Transporters Using 123I-ADAM: Optimal Imaging Time After Bolus Injection and Long-Term Test-Retest in Healthy Volunteers
J. Nucl. Med., August 1, 2005; 46(8): 1301 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. K. Staley, C. Gottschalk, I. L. Petrakis, R. Gueorguieva, S. O'Malley, R. Baldwin, P. Jatlow, N. P. L. G. Verhoeff, E. Perry, D. Weinzimmer, et al.
Cortical {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptors in Recovery From Alcohol Dependence: Relationship to Features of Alcohol Dependence and Cigarette Smoking
Arch Gen Psychiatry, August 1, 2005; 62(8): 877 - 888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. D. Bremner, R. B. Innis, S. M. Southwick, L. Staib, S. Zoghbi, and D. S. Charney
Decreased Benzodiazepine Receptor Binding in Prefrontal Cortex in Combat-Related Posttraumatic Stress Disorder
Am J Psychiatry, July 1, 2000; 157(7): 1120 - 1126.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.